Issues in Medicine: Equity and Site Neutrality.
No authors listed.
No abstract text available.
- J Vitreoretin Dis. 2024 Dec 13;:24741264241305123
[PMID: 39678936]
- J Vitreoretin Dis. 2024 Dec 7;:24741264241303714
[PMID: 39654699]
- J Vitreoretin Dis. 2024 Oct 30;:24741264241293908
[PMID: 39539819]
- J Vitreoretin Dis. 2024 Dec 31;:24741264241306422
[PMID: 39748913]
- J Vitreoretin Dis. 2024 Oct 30;:24741264241294159
[PMID: 39539837]
- J Vitreoretin Dis. 2024 Nov 12;:24741264241297684
[PMID: 39544710]
- J Vitreoretin Dis. 2024 Oct 30;:24741264241294165
[PMID: 39539828]
- J Vitreoretin Dis. 2024 Nov 13;:24741264241297945
[PMID: 39544709]
- J Vitreoretin Dis. 2024 Nov 14;:24741264241297936
[PMID: 39554631]
- J Vitreoretin Dis. 2024 Dec 20;:24741264241304810
[PMID: 39711691]
- J Vitreoretin Dis. 2024 Dec 30;:24741264241308495
[PMID: 39742143]
- J Vitreoretin Dis. 2024 Dec 7;:24741264241305103
[PMID: 39654700]
- J Vitreoretin Dis. 2024 Dec 30;:24741264241305107
[PMID: 39742141]
- J Vitreoretin Dis. 2024 Nov 28;:24741264241301812
[PMID: 39619484]
- J Vitreoretin Dis. 2024 Dec 13;:24741264241305105
[PMID: 39678938]
- J Vitreoretin Dis. 2024 Oct 30;:24741264241277407
[PMID: 39539841]
- J Vitreoretin Dis. 2024 Dec 7;:24741264241302858
[PMID: 39654701]
- J Vitreoretin Dis. 2024 Dec 13;:24741264241302859
[PMID: 39678940]
- J Vitreoretin Dis. 2024 Dec 30;:24741264241305116
[PMID: 39742144]
- J Vitreoretin Dis. 2024 Dec 13;:24741264241304813
[PMID: 39678939]
- J Vitreoretin Dis. 2024 Nov 14;:24741264241296464
[PMID: 39554625]
- J Vitreoretin Dis. 2024 Sep 24;:24741264241278822
[PMID: 39539823]
- J Vitreoretin Dis. 2024 Dec 25;:24741264241308496
[PMID: 39726951]
- J Vitreoretin Dis. 2025 Feb 15;:24741264241302870
[PMID: 39963690]
- J Vitreoretin Dis. 2024 Nov 8;:24741264241296465
[PMID: 39539843]
- J Vitreoretin Dis. 2024 Dec 13;:24741264241301763
[PMID: 39678937]